Stay updated on IV Ganaxolone in Postpartum Depression Clinical Trial
Sign up to get notified when there's something new on the IV Ganaxolone in Postpartum Depression Clinical Trial page.

Latest updates to the IV Ganaxolone in Postpartum Depression Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the ganaxolone postpartum-depression study is displayed with its study details, results measures, participant criteria, and supporting documents instead of an access-denied error.SummaryDifference56%

- Check13 days agoChange DetectedThe site footer revision identifier changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA banner about the NIH website transition appears above the unchanged 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.7.1 instead of v3.7.0. The study page continues to show a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content. Access to the study details is blocked.SummaryDifference18%

- Check62 days agoChange DetectedThe page now shows Revision: v3.7.0 replacing Revision: v3.6.6, reflecting an administrative update to the study record’s document version.SummaryDifference0.1%

Stay in the know with updates to IV Ganaxolone in Postpartum Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IV Ganaxolone in Postpartum Depression Clinical Trial page.